209 related articles for article (PubMed ID: 11992583)
1. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
[TBL] [Abstract][Full Text] [Related]
2. Cardiovirulent coxsackieviruses and the decay-accelerating factor (CD55) receptor.
Martino TA; Petric M; Brown M; Aitken K; Gauntt CJ; Richardson CD; Chow LH; Liu PP
Virology; 1998 May; 244(2):302-14. PubMed ID: 9601501
[TBL] [Abstract][Full Text] [Related]
3. Attachment of coxsackievirus B3 variants to various cell lines: mapping of phenotypic differences to capsid protein VP1.
Schmidtke M; Selinka HC; Heim A; Jahn B; Tonew M; Kandolf R; Stelzner A; Zell R
Virology; 2000 Sep; 275(1):77-88. PubMed ID: 11017789
[TBL] [Abstract][Full Text] [Related]
4. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.
Martino TA; Petric M; Weingartl H; Bergelson JM; Opavsky MA; Richardson CD; Modlin JF; Finberg RW; Kain KC; Willis N; Gauntt CJ; Liu PP
Virology; 2000 May; 271(1):99-108. PubMed ID: 10814575
[TBL] [Abstract][Full Text] [Related]
5. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate.
Milstone AM; Petrella J; Sanchez MD; Mahmud M; Whitbeck JC; Bergelson JM
J Virol; 2005 Jan; 79(1):655-60. PubMed ID: 15596863
[TBL] [Abstract][Full Text] [Related]
6. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
Goodfellow IG; Evans DJ; Blom AM; Kerrigan D; Miners JS; Morgan BP; Spiller OB
J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
[TBL] [Abstract][Full Text] [Related]
8. Virus-receptor interactions of coxsackie B viruses and their putative influence on cardiotropism.
Selinka HC; Wolde A; Sauter M; Kandolf R; Klingel K
Med Microbiol Immunol; 2004 May; 193(2-3):127-31. PubMed ID: 12920584
[TBL] [Abstract][Full Text] [Related]
9. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
[TBL] [Abstract][Full Text] [Related]
10. Specificity of coxsackievirus B3 interaction with human, but not murine, decay-accelerating factor: replacement of a single residue within short consensus repeat 2 prevents virus attachment.
Pan J; Zhang L; Organtini LJ; Hafenstein S; Bergelson JM
J Virol; 2015 Jan; 89(2):1324-8. PubMed ID: 25392210
[TBL] [Abstract][Full Text] [Related]
11. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3.
Pasch A; Küpper JH; Wolde A; Kandolf R; Selinka HC
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3153-3158. PubMed ID: 10567646
[TBL] [Abstract][Full Text] [Related]
12. Development of a recombinant CHO cell model for the investigation of CAR and DAF role during early steps of echovirus 6 infection.
Renois F; Hong SS; Le Naour R; Gafa V; Talmud D; Andréoletti L; Lévêque N
Virus Res; 2011 Jun; 158(1-2):46-54. PubMed ID: 21420451
[TBL] [Abstract][Full Text] [Related]
13. Decay-accelerating factor (CD55) promotes CD1d expression and Vgamma4+ T-cell activation in coxsackievirus B3-induced myocarditis.
Huber S; Song WC; Sartini D
Viral Immunol; 2006; 19(2):156-66. PubMed ID: 16817758
[TBL] [Abstract][Full Text] [Related]
14. Human pancreatic islet endothelial cells express coxsackievirus and adenovirus receptor and are activated by coxsackie B virus infection.
Zanone MM; Favaro E; Ferioli E; Huang GC; Klein NJ; Perin PC; Peakman M; Conaldi PG; Camussi G
FASEB J; 2007 Oct; 21(12):3308-17. PubMed ID: 17494992
[TBL] [Abstract][Full Text] [Related]
15. Chinese hamster ovary cells are non-permissive towards infection with coxsackievirus B3 despite functional virus-receptor interactions.
Kramer B; Huber M; Kern C; Klingel K; Kandolf R; Selinka HC
Virus Res; 1997 May; 48(2):149-56. PubMed ID: 9175253
[TBL] [Abstract][Full Text] [Related]
16. Heparan sulfates and coxsackievirus-adenovirus receptor: each one mediates coxsackievirus B3 PD infection.
Zautner AE; Körner U; Henke A; Badorff C; Schmidtke M
J Virol; 2003 Sep; 77(18):10071-7. PubMed ID: 12941917
[TBL] [Abstract][Full Text] [Related]
17. Interaction of decay-accelerating factor with coxsackievirus B3.
Hafenstein S; Bowman VD; Chipman PR; Bator Kelly CM; Lin F; Medof ME; Rossmann MG
J Virol; 2007 Dec; 81(23):12927-35. PubMed ID: 17804498
[TBL] [Abstract][Full Text] [Related]
18. Experimental SSM-CVB3 infection in macaques.
Han T; He W; Song D; Zhao K; Wu C; Gao F; Lu H; Gai X; Wang X; Li F; Ji C; Lin X
Exp Mol Pathol; 2012 Feb; 92(1):131-9. PubMed ID: 22079478
[TBL] [Abstract][Full Text] [Related]
19. Internalization and trafficking mechanisms of coxsackievirus B3 in HeLa cells.
Chung SK; Kim JY; Kim IB; Park SI; Paek KH; Nam JH
Virology; 2005 Mar; 333(1):31-40. PubMed ID: 15708590
[TBL] [Abstract][Full Text] [Related]
20. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]